BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2459520)

  • 1. Quantitative analysis of the interaction of [3H]spiroperidol with serotonin and dopamine receptors.
    McGonigle P
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S73-7. PubMed ID: 2459520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):184-92. PubMed ID: 3969067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of the apparent affinity of the striatal dopamine receptors for the radioligand[3H]spiperone [( 3H]spiroperidol).
    Hruska RE
    J Neurosci Res; 1984; 12(4):571-81. PubMed ID: 6512888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
    Zahniser NR; Dubocovich ML
    J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative determination of dopamine receptor subtypes not linked to activation of adenylate cyclase in rat striatum.
    Huff RM; Molinoff PB
    Proc Natl Acad Sci U S A; 1982 Dec; 79(23):7561-5. PubMed ID: 6961433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pyridoxine deficiency in young rats on high-affinity serotonin and dopamine receptors.
    Paulose CS; Dakshinamurti K
    J Neurosci Res; 1985; 14(2):263-70. PubMed ID: 4046074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of binding sites for 3H-spiroperidol in human retina.
    McGonigle P; Wax MB; Molinoff PB
    Invest Ophthalmol Vis Sci; 1988 May; 29(5):687-94. PubMed ID: 2452802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA; Davis KH; Titeler M
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assay of dopamine receptors with [alpha-3H]flupenthixol.
    Huff RM; Molinoff PB
    J Pharmacol Exp Ther; 1985 Jan; 232(1):57-61. PubMed ID: 3965700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of D-2 dopamine receptors in a tumor of the rat anterior pituitary gland.
    Lin C; McGonigle P; Molinoff PB
    J Pharmacol Exp Ther; 1987 Sep; 242(3):950-6. PubMed ID: 2958621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
    Zahniser NR; Molinoff PB
    Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive method for the quantitative determination of dopamine receptor subtypes.
    McGonigle P; Huff RM; Molinoff PB
    Ann N Y Acad Sci; 1984; 430():77-90. PubMed ID: 6331265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer imaging and analysis of dopamine (D2) and serotonin (S2) binding sites in rat basal ganglia or neocortex labeled by [3H]spiroperidol.
    Altar CA; Kim H; Marshall JF
    J Pharmacol Exp Ther; 1985 May; 233(2):527-38. PubMed ID: 3889277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography.
    Beckstead RM; Wooten GF; Trugman JM
    J Comp Neurol; 1988 Feb; 268(1):131-45. PubMed ID: 2964456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H]Ro 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner.
    Nakajima T; Iwata K
    Mol Pharmacol; 1984 Nov; 26(3):430-8. PubMed ID: 6149457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors.
    McGonigle P; Boyson SJ; Reuter S; Molinoff PB
    Synapse; 1989; 3(1):74-82. PubMed ID: 2521960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compartment-specific changes in the density of choline and dopamine uptake sites and muscarinic and dopaminergic receptors during the development of the baboon striatum: a quantitative receptor autoradiographic study.
    Lowenstein PR; Slesinger PA; Singer HS; Walker LC; Casanova MF; Raskin LS; Price DL; Coyle JT
    J Comp Neurol; 1989 Oct; 288(3):428-46. PubMed ID: 2794143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two classes of [3H]spiperone binding sites in bovine neurohypophysis: D-2 receptors and putative 5-HT2 receptors.
    Treiman M; Andersen PH
    J Recept Res; 1989; 9(4-5):297-312. PubMed ID: 2574236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
    Chatterjee TK; Scott CE; Vazquez DM; Bhatnagar RK
    Mol Pharmacol; 1988 Apr; 33(4):402-13. PubMed ID: 3357484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.